• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

被非酒精性脂肪性肝病（NAFLD）搞得晕头转向：马虽然已经出了马厩，但不应让我们晕头转向。

Baffled by NAFLD: the horse might be out of the barn but should not take us for a ride.

机构信息

University of Michigan, 2800 Plymouth Rd, Bldg 16, Floor 4, 016-400S-25, Ann Arbor, MI 48109-2800. Email:

出版信息

Am J Manag Care. 2021 Sep;27(9):364-365. doi: 10.37765/ajmc.2021.88671.

DOI:10.37765/ajmc.2021.88671
PMID:34533904
Abstract

As awareness of nonalcoholic fatty liver disease (NAFLD) rises, it is essential to develop and implement a rigorously determined approach to identify patients who will, or will not, benefit from diagnostic evaluation.

摘要

随着人们对非酒精性脂肪性肝病（NAFLD）认识的提高，制定并实施一种严格确定的方法来识别哪些患者将从诊断评估中获益或不会获益至关重要。

相似文献

1
Baffled by NAFLD: the horse might be out of the barn but should not take us for a ride.被非酒精性脂肪性肝病（NAFLD）搞得晕头转向：马虽然已经出了马厩，但不应让我们晕头转向。
Am J Manag Care. 2021 Sep;27(9):364-365. doi: 10.37765/ajmc.2021.88671.
2
Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations.同时患有非酒精性脂肪性肝病和 2 型糖尿病：诊断和治疗注意事项。
Expert Rev Gastroenterol Hepatol. 2019 Sep;13(9):849-866. doi: 10.1080/17474124.2019.1649981. Epub 2019 Aug 8.
3
Protocol for a randomised trial testing a community fibrosis assessment service for patients with suspected non-alcoholic fatty liver disease: LOCal assessment and triage evaluation of non-alcoholic fatty liver disease (LOCATE-NAFLD).一项针对疑似非酒精性脂肪性肝病患者的社区纤维化评估服务的随机试验方案：非酒精性脂肪性肝病的局部评估和分诊评估 (LOCATE-NAFLD)。
BMC Health Serv Res. 2020 Apr 21;20(1):335. doi: 10.1186/s12913-020-05233-2.
4
Severity of nonalcoholic fatty liver disease on sonography and risk of coronary heart disease.超声检查中非酒精性脂肪性肝病的严重程度与冠心病风险
J Clin Ultrasound. 2017 Sep;45(7):391-399. doi: 10.1002/jcu.22472. Epub 2017 Mar 28.
5
[Investigation and analysis of the knowledge of nonalcoholic fatty liver disease among residents in Hebei Province, China].[中国河北省居民非酒精性脂肪性肝病知识的调查与分析]
Zhonghua Gan Zang Bing Za Zhi. 2017 Oct 20;25(10):760-765. doi: 10.3760/cma.j.issn.1007-3418.2017.10.008.
6
Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.美国一个代表性队列中，非酒精性脂肪性肝病的知晓率正在上升，但仍然很低。
Dig Dis Sci. 2020 Apr;65(4):978-986. doi: 10.1007/s10620-019-05700-9. Epub 2019 Jun 11.
7
[Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].[中国北京387名肥胖儿童及青少年的非酒精性脂肪性肝病患病率及代谢异常情况]
Zhonghua Liu Xing Bing Xue Za Zhi. 2013 May;34(5):446-50.
8
Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.非酒精性脂肪性肝病：夏威夷初级保健提供者的重要考虑因素。
Hawaii J Health Soc Welf. 2020 Jun 1;79(6):180-186.
9
Nonalcoholic Fatty Liver Disease: An Update on the Diagnosis.非酒精性脂肪性肝病：诊断进展
Gene Expr. 2019 Nov 4;19(3):187-198. doi: 10.3727/105221619X15553433838609. Epub 2019 Apr 22.
10
The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.他汀类药物单独使用，或与吡格列酮及其他药物联合使用，用于治疗非酒精性脂肪性肝病/非酒精性脂肪性肝炎及相关心血管风险。专家小组声明。
Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4.

引用本文的文献

1
Statin prescribing patterns in patient-centered medical home patients with NAFLD.在以患者为中心的医疗家庭中，有非酒精性脂肪性肝病的患者中他汀类药物的开具情况。
Am J Manag Care. 2023 Aug;29(8):408-413. doi: 10.37765/ajmc.2023.89406.